Підписатись
Oskar Hansson
Oskar Hansson
Professor of Neurology, Lund University
Підтверджена електронна адреса в med.lu.se - Домашня сторінка
Назва
Посилання
Посилання
Рік
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson, H Zetterberg, P Buchhave, E Londos, K Blennow, L Minthon
The Lancet Neurology 5 (3), 228-234, 2006
21792006
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
14672009
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial
JR Sims, JA Zimmer, CD Evans, M Lu, P Ardayfio, JD Sparks, AM Wessels, ...
Jama 330 (6), 512-527, 2023
11852023
Brain charts for the human lifespan
RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ...
Nature 604 (7906), 525-533, 2022
11142022
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ...
The Lancet Neurology 19 (5), 422-433, 2020
10762020
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders
S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, ...
Jama 324 (8), 772-781, 2020
10572020
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
S Janelidze, N Mattsson, S Palmqvist, R Smith, TG Beach, GE Serrano, ...
Nature medicine 26 (3), 379-386, 2020
10342020
Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease
S Budd Haeberlein, PS Aisen, F Barkhof, S Chalkias, T Chen, S Cohen, ...
The journal of prevention of Alzheimer's disease 9 (2), 197-210, 2022
9852022
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
S Palmqvist, M Schöll, O Strandberg, N Mattsson, E Stomrud, H Zetterberg, ...
Nature communications 8 (1), 1214, 2017
8252017
Cerebrospinal fluid levels ofβ-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia
P Buchhave, L Minthon, H Zetterberg, ÅK Wallin, K Blennow, O Hansson
Archives of general psychiatry 69 (1), 98-106, 2012
8252012
Biomarkers for neurodegenerative diseases
O Hansson
Nature medicine 27 (6), 954-963, 2021
8102021
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease
MM Zeron, O Hansson, N Chen, CL Wellington, BR Leavitt, P Brundin, ...
Neuron 33 (6), 849-860, 2002
7452002
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
6972017
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
CE Teunissen, IMW Verberk, EH Thijssen, L Vermunt, O Hansson, ...
The Lancet Neurology 21 (1), 66-77, 2022
6922022
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
6822019
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts
O Hansson, J Seibyl, E Stomrud, H Zetterberg, JQ Trojanowski, T Bittner, ...
Alzheimer's & dementia 14 (11), 1470-1481, 2018
6642018
Plasma β-amyloid in Alzheimer’s disease and vascular disease
S Janelidze, E Stomrud, S Palmqvist, H Zetterberg, D Van Westen, ...
Scientific reports 6 (1), 26801, 2016
6452016
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
JW Vogel, AL Young, NP Oxtoby, R Smith, R Ossenkoppele, ...
Nature medicine 27 (5), 871-881, 2021
5982021
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity
D Lindqvist, S Janelidze, P Hagell, S Erhardt, M Samuelsson, L Minthon, ...
Biological psychiatry 66 (3), 287-292, 2009
5982009
CSF and blood biomarkers for Parkinson's disease
L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ...
The Lancet Neurology 18 (6), 573-586, 2019
5952019
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20